The Jordanian Method for Stem Cells

The Jordanian Method is a registered trademark at the Ministry of Industry and Trade in Amman, Jordan. The Jordanian Method encompasses the preparation of autologous, purified, and unmanipulated populations of stem cells by clinically approved methods and adhering to the highest safety parameters to be used in the treatment of chronic and untreatable diseases. The essence of this method is using autologous stem cells, i.e. from the same patient, to avoid rejection by the patient’s immune system, graft-versus-host diseases (GvHD), transmission of infectious diseases and the bypass of regulatory hurdles. Additionally, to attain the maximum benefit out of the transplanted stem cell population, the Jordanian method ensures that the stem cells are of high purity levels. Studies have shown that certain populations of stem cells possess higher regeneration and curative power than others. Obtaining high purity levels can be achieved by purification of specific populations of stem cells and by the removal of contaminating components that can be present in the initial sample such as platelets, red blood cells (RBCs), and white blood cells (WBCs). Platelets can release platelet factors that may alter the function of stem cells. In blood, the number of RBCs is a 100,000 fold larger than the number of stem cells. Hence the removal of RBCs from the blood accounts for a higher percentage of stem cell population in the sample. The presence of WBCs in the sample could also induce an auto-immune reaction if